Opus Genetics, Inc.

IRD·NasdaqCM·Healthcare
Compare
4.6400−0.0100 (−0.22%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours4.6700+0.0300 (+0.65%)Oct 12, 5:26 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.6500
Open4.6300
Day range4.60004.8800
52-week range1.70007.0700
Off day high−4.92%
Off 52-week high−34.37%
Volume1.62M
Avg. volume (3M)2.38M
Market cap386.03M
EPS (TTM)-1.27
Forward P/E-6.49
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.62
Shares outstanding83.20M
Short interest16.45% of float
Earnings dateAug 6, 2026 (est.)
Analyst target13.4118
Profit margin0.00%

Against its peers

Compare in full ›
IRD OCGN MGTX RGNX STOK DSGN
Market cap 386.03M 321.21M 996.93M 512.92M 1.56B 682.77M
P/E (TTM) — — 11.9 — — —
Forward P/E -6.5 -3.7 -6.8 -2.6 -6.8 -6.7
Price/book -29.6 -19.3 4.5 5.9 4.4 3.4
Dividend yield — — — — — —
1-year change +132.50% −40.25% +36.53% −28.84% −18.46% +79.51%
Today −0.22% −0.87% −2.90% −3.72% −2.38% −6.35%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All IRD news ›
Markets Daily·

Opus Genetics (NASDAQ:IRD) Price Target Raised to $17.00

Posted by Mitch Edgeman on Oct 6th, 2026 Opus Genetics (NASDAQ:IRD – Get Free Report) had its price target raised by equities research analysts at JonesTrading from $10.00 to $17.00 in a report released on Tuesday, Benzinga reports. The…

From articles in the 4Search news index.

In the news

4mentions in 30 days
4with it in the headline
Positivesentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.